Discovery of Q203, a potent clinical candidate for the treatment of tuberculosis
Pethe, Kevin Bifani, Pablo Jang, Jichan Kang, Sunhee Park, Seijin Ahn, Sujin Jiricek, Jan Jung, Juyoung Jeon, Hee Kyoung Cechetto, Jonathan Christophe, Thierry Lee, Honggun Kempf, Marie Jackson, Mary Lenaerts, Anne J. Ha Pham Jones, Victoria Seo, Min Jung Kim, Young Mi Seo, Mooyoung Seo, Jeong Jea Park, Dongsik Ko, Yoonae Choi, Inhee Kim, Ryangyeo Kim, Se Yeon Lim, SeungBin Yim, Seung-Ae Nam, Jiyoun Kang, Hwankyu Kwon, Haejin Oh, Chun-Taek Cho, Yoojin Jang, Yunhee Kim, Junghwan Chua, Adeline Tan, Bee Huat Nanjundappa, Mahesh B. Rao, Srinivasa P. S. Barnes, Whitney S. Wintjens, Rene Walker, John R. Alonso, Sylvie Lee, Saeyeon Kim, Jungjun Oh, Soohyun Oh, Taegwon Nehrbass, Ulf Han, Sung-Jun No, Zaesung Lee, Jinhwa Brodin, Priscille Cho, Sang-Nae Nam, Kiyean Kim, Jaeseung
Nature medicine, 2013-9
https://doi.org/10.1038/nm.3262
Mary Jackson
Jackson Mary
ORCID: 0000-0002-9212-0258
Analysis of uracil phosphoribosyltransferase expression in Mycobacterium tuberculosis and evaluation of upp knockout strain in infected mice 10.1093/femsle/fnx023
Biosynthesis of the Methylthioxylose Capping Motif of Lipoarabinomannan in Mycobacterium tuberculosis. 10.1021/acschembio.6b01071
Synergistic interactions of MmpL3 inhibitors with antitubercular compounds in vitro. 10.1128/AAC.02399-16
Assembling of the Mycobacterium tuberculosis Cell Wall Core 10.1074/jbc.M116.739227
Identification of a Novel Mycobacterial Arabinosyltransferase Activity Which Adds an Arabinosyl Residue to alpha-D-Mannosyl Residues 10.1021/acschembio.6b00093
Metabolic profile of Mycobacterium smegmatis reveals Mce4 proteins are relevant for cell wall lipid homeostasis 10.1007/s11306-016-1035-4
Structural basis for selective recognition of acyl chains by the membrane-associated acyltransferase PatA 10.1038/ncomms10906
Structure-Function Profile of MmpL3, the Essential Mycolic Acid Transporter from Mycobacterium tuberculosis 10.1021/acsinfecdis.6b00095
Synthesis and evaluation of new 2-aminothiophenes against Mycobacterium tuberculosis 10.1039/c6ob00821f
Therapeutic Potential of the Mycobacterium tuberculosis Mycolic Acid Transporter, MmpL3 10.1128/AAC.00826-16
A glycomic approach reveals a new mycobacterial polysaccharide 10.1093/glycob/cwv061
Covalent Modification of the Mycobacterium tuberculosis FAS-II Dehydratase by Isoxyl and Thiacetazone 10.1021/id500032q
CpsA, a LytR-CpsA-Psr Family Protein in Mycobacterium marinum, Is Required for Cell Wall Integrity and Virulence 10.1128/IAI.03081-14
Draft Genome Sequence of Mycobacterium chelonae Type Strain ATCC 35752 10.1128/genomeA.00536-15
Partial Saturation of Menaquinone in Mycobacterium tuberculosis: Function and Essentiality of a Novel Reductase, MenJ 10.1021/acscentsci.5b00212
The presence of a galactosamine substituent on the arabinogalactan of Mycobacterium tuberculosis abrogates full maturation of human peripheral blood monocyte-derived dendritic cells and increases secretion of IL-10 10.1016/j.tube.2015.04.002
A Noncompetitive Inhibitor for Mycobacterium tuberculosis's Class IIa Fructose 1,6-Bisphosphate Aldolase 10.1021/bi401022b
A Single Arabinan Chain Is Attached to the Phosphatidylinositol Mannosyl Core of the Major Immunomodulatory Mycobacterial Cell Envelope Glycoconjugate, Lipoarabinomannan 10.1074/jbc.M114.599415
Analysis of a panel of rapidly growing mycobacteria for resistance to aldehyde-based disinfectants 10.1016/j.ajic.2014.05.014
Biosynthesis and Translocation of Unsulfated Acyltrehaloses in Mycobacterium tuberculosis 10.1074/jbc.M114.581199
Gene Replacement in Mycobacterium chelonae: Application to the Construction of Porin Knock-Out Mutants 10.1371/journal.pone.0094951
Genetics of Capsular Polysaccharides and Cell Envelope (Glyco)lipids 10.1128/microbiolspec.MGM2-0021-2013
High-level Relatedness among Mycobacterium abscessus subsp massiliense Strains from Widely Separated Outbreaks 10.3201/eid2003.131106
Inactivation of Fructose-1,6-Bisphosphate Aldolase Prevents Optimal Co-catabolism of Glycolytic and Gluconeogenic Carbon Substrates in Mycobacterium tuberculosis 10.1371/journal.ppat.1004144
Long-term Survival and Virulence of Mycobacterium leprae in Amoebal Cysts 10.1371/journal.pntd.0003405
LprG-Mediated Surface Expression of Lipoarabinomannan Is Essential for Virulence of Mycobacterium tuberculosis 10.1371/journal.ppat.1004376
Mycobacterium tuberculosis Lipoprotein LprG Binds Lipoarabinomannan and Determines Its Cell Envelope Localization to Control Phagolysosomal Fusion 10.1371/journal.ppat.1004471
Novel Insights into the Mechanism of Inhibition of MmpL3, a Target of Multiple Pharmacophores in Mycobacterium tuberculosis 10.1128/AAC.03229-14
Purification and characterization of the acyltransferase involved in biosynthesis of the major mycobacterial cell envelope glycolipid - Monoacylated phosphatidylinositol dimannoside 10.1016/j.pep.2014.04.014
RND transporters protect Corynebacterium glutamicum from antibiotics by assembling the outer membrane 10.1002/mbo3.182
Role of the Mce1 transporter in the lipid homeostasis of Mycobacterium tuberculosis 10.1016/j.tube.2013.12.005
Structure-function relationships of membrane-associated GT-B glycosyltransferases 10.1093/glycob/cwt101
The cell envelope glycoconjugates of Mycobacterium tuberculosis 10.3109/10409238.2014.925420
The Mycobacterial Cell Envelope-Lipids 10.1101/cshperspect.a021105
Bacterial protein-O-mannosylating enzyme is crucial for virulence of Mycobacterium tuberculosis 10.1073/pnas.1219704110
Cooccurrence of Free-Living Amoebae and Nontuberculous Mycobacteria in Hospital Water Networks, and Preferential Growth of Mycobacterium avium in Acanthamoeba lenticulata 10.1128/AEM.03823-12
Design, synthesis and anti-tuberculosis activity of 1-adamantyl-3-heteroaryl ureas with improved in vitro pharmacokinetic properties 10.1016/j.bmc.2013.02.028
Discovery of Q203, a potent clinical candidate for the treatment of tuberculosis 10.1038/nm.3262
Genome Sequence of an Epidemic Isolate of Mycobacterium abscessus subsp. bolletii from Rio de Janeiro, Brazil 10.1128/genomeA.00617-13
Mechanism of inhibition of Mycobacterium tuberculosis antigen 85 by ebselen 10.1038/ncomms3748
Phylogenomics of Brazilian epidemic isolates of Mycobacterium abscessus subsp bolletii reveals relationships of global outbreak strains 10.1016/j.meegid.2013.09.012
Progress in targeting cell envelope biogenesis in Mycobacterium tuberculosis 10.2217/fmb.13.52
Regulation of Mycolactone, the Mycobacterium ulcerans Toxin, Depends on Nutrient Source 10.1371/journal.pntd.0002502
Subfractionation and analysis of the cell envelope (lipo)polysaccharides of Mycobacterium tuberculosis. 10.1007/978-1-62703-245-2_19
Updating and curating metabolic pathways of TB 10.1016/j.tube.2012.11.001
A Common Mechanism of Inhibition of the Mycobacterium tuberculosis Mycolic Acid Biosynthetic Pathway by Isoxyl and Thiacetazone 10.1074/jbc.M112.400994
A Small Multidrug Resistance-like Transporter Involved in the Arabinosylation of Arabinogalactan and Lipoarabinomannan in Mycobacteria 10.1074/jbc.M112.400986
Aldehyde-resistant mycobacteria bacteria associated with the use of endoscope reprocessing systems 10.1016/j.ajic.2011.11.004
Impact of the deletion of the six mce operons in Mycobacterium smegmatis 10.1016/j.micinf.2012.01.007
Inhibition of mycolic acid transport across the Mycobacterium tuberculosis plasma membrane 10.1038/NCHEMBIO.794
Mechanistic Insights into the Retaining Glucosyl-3-phosphoglycerate Synthase from Mycobacteria 10.1074/jbc.M112.368191
Screening a library of 1600 adamantyl ureas for anti-Mycobacterium tuberculosis activity in vitro and for better physical chemical properties for bioavailability 10.1016/j.bmc.2012.03.058
Glycolytic and Non-glycolytic Functions of Mycobacterium tuberculosis Fructose-1,6-bisphosphate Aldolase, an Essential Enzyme Produced by Replicating and Non-replicating Bacilli 10.1074/jbc.M111.259440
Increased Virulence of an Epidemic Strain of Mycobacterium massiliense in Mice 10.1371/journal.pone.0024726
Investigation of ABC transporter from mycobacterial arabinogalactan biosynthetic cluster 10.4149/gpb_2011_03_239
Reconstitution of Functional Mycobacterial Arabinosyltransferase AftC Proteoliposome and Assessment of Decaprenylphosphorylarabinose Analogues as Arabinofuranosyl Donors 10.1021/cb200091m
The structure-activity relationship of urea derivatives as anti-tuberculosis agents 10.1016/j.bmc.2011.07.034
An Oligopeptide Transporter of Mycobacterium tuberculosis Regulates Cytokine Release and Apoptosis of Infected Macrophages 10.1371/journal.pone.0012225
Biosynthetic Origin of the Galactosamine Substituent of Arabinogalactan in Mycobacterium tuberculosis 10.1074/jbc.M110.188110
Molecular Basis of Phosphatidyl-myo-inositol Mannoside Biosynthesis and Regulation in Mycobacteria 10.1074/jbc.R110.168328
Rational Design, Synthesis, and Evaluation of New Selective Inhibitors of Microbial Class II (Zinc Dependent) Fructose Bis-phosphate Aldolases 10.1021/jm1009814
Synthesis, biological activity, and evaluation of the mode of action of novel antitubercular benzofurobenzopyrans substituted on A ring 10.1016/j.ejmech.2010.09.048
AftD, a novel essential arabinofuranosyltransferase from mycobacteria 10.1093/glycob/cwp116
Chapter 2: Biogenesis of the cell wall and other glycoconjugates of Mycobacterium tuberculosis. 10.1016/S0065-2164(09)69002-X
High Content Screening Identifies Decaprenyl-Phosphoribose 2 ' Epimerase as a Target for Intracellular Antimycobacterial Inhibitors 10.1371/journal.ppat.1000645
Identification of a Polyprenylphosphomannosyl Synthase Involved in the Synthesis of Mycobacterial Mannosides 10.1128/JB.00431-09
Initiation of Methylglucose Lipopolysaccharide Biosynthesis in Mycobacteria 10.1371/journal.pone.0005447
Mce3R, a TetR-type transcriptional repressor, controls the expression of a regulon involved in lipid metabolism in Mycobacterium tuberculosis 10.1099/mic.0.027086-0
New Insights into the Early Steps of Phosphatidylinositol Mannoside Biosynthesis in Mycobacteria PimB' IS AN ESSENTIAL ENZYME OF MYCOBACTERIUM SMEGMATIS 10.1074/jbc.M109.030593
Polymethylated Polysaccharides from Mycobacterium Species Revisited 10.1074/jbc.R800047200
Role of Porins in the Susceptibility of Mycobacterium smegmatis and Mycobacterium chelonae to Aldehyde-Based Disinfectants and Drugs 10.1128/AAC.00590-09
Substrate-induced Conformational Changes in the Essential Peripheral Membrane-associated Mannosyltransferase PimA from Mycobacteria IMPLICATIONS FOR CATALYSIS 10.1074/jbc.M109.003947
A point mutation in the two-component regulator PhoP-PhoR accounts for the absence of polyketide-derived acyltrehaloses but not that of phthiocerol dimycocerosates in Mycobacterium tuberculosis H37Ra 10.1128/JB.01465-07
Capsular glucan and intracellular glycogen of Mycobacterium tuberculosis: biosynthesis and impact on the persistence in mice 10.1111/j.1365-2958.2008.06445.x
Lipoarabinomannan of Mycobacterium: Mannose capping by a multifunctional terminal mannosyltransferase 10.1073/pnas.0807761105
N-D-Aldopentofuranosyl-N '-[p-(isoamyloxy)phenyl]-thiourea derivatives: Potential anti-TB therapeutic agents 10.1016/j.bmcl.2008.03.033
Preliminary crystallographic analysis of GpgS, a key glucosyltransferase involved in methylglucose lipopolysaccharide biosynthesis in Mycobacterium tuberculosis 10.1107/S1744309108032892
Synthesis and biochemical evaluation of selective inhibitors of class II fructose bisphosphate aldolases: towards new synthetic antibiotics 10.1002/chem.200800857
The immunomodulatory lipoglycans, lipoarabinomannan and lipomannan, are exposed at the mycobacterial cell surface 10.1016/j.tube.2008.04.002
Genetic basis for the biosynthesis of methylglucose lipopolysaccharides in Mycobacterium tuberculosis 10.1074/jbc.M702676200
Impact of Mycobacterium ulcerans biofilm on transmissibility to ecological niches and Buruli ulcer pathogenesis 10.1371/journal.ppat.0030062
Isoxyl activation is required for bacteriostatic activity against Mycobacterium tuberculosis 10.1128/AAC.00433-07
Long-chain multiple methyl-branched fatty acid-containing lipids of Mycobacterium tuberculosis: Biosynthesis, transport, regulation and biological activities 10.1016/j.tube.2006.05.003
Molecular recognition and interfacial catalysis by the essential phosphatidylinositol mannosyltransferase PimA from mycobacteria 10.1074/jbc.M702087200
New insights into the biosynthesis of mycobacterial lipomannan arising from deletion of a conserved gene 10.1074/jbc.M703389200
Signature-tagged transposon mutagenesis identifies novel Mycobacterium tuberculosis genes involved in the parasitism of human macrophages 10.1128/IAI.00058-06
The glycosyltransferases of Mycobacterium tuberculosis - roles in the synthesis of arabinogalaetan, lipoarahinolrnlannan, and other glyeoeonjugates 10.1093/glycob/cwm010
Biosynthesis of mycobacterial lipoarabinomannan: Role of a branching mannosyltransferase 10.1073/pnas.0603049103
Comparative investigation of the pathogenicity of three Mycobacterium tuberculosis mutants defective in the synthesis of p-hydroxybenzoic acid derivatives 10.1016/j.micinf.2006.04.008
Inactivation of Rv2525c, a Substrate of the Twin Arginine Translocation (Tat) System of Mycobacterium tuberculosis, Increases -Lactam Susceptibility and Virulence 10.1128/JB.00631-06
LppX is a lipoprotein required for the translocation of phthiocerol dimycocerosates to the surface of Mycobacterium tuberculosis 10.1038/sj.emboj.7601048
The Ser/Thr protein kinase PknB is essential for sustaining mycobacterial growth 10.1128/JB.00963-06
The structure of PknB in complex with mitoxantrone, an ATP-competitive inhibitor, suggests a mode of protein kinase regulation in mycobacteria 10.1016/j.febslet.2006.04.046
The virulence-associated two-component PhoP-PhoR system controls the biosynthesis of polyketide-derived lipids in Mycobacterium tuberculosis 10.1074/jbc.C500388200
Crystallization and preliminary crystallographic analysis of PimA, an essential mannosyltransferase from Mycobacterium smegmatis 10.1107/S1744309105012364
Deciphering the molecular bases of Mycobacterium tuberculosis binding to the lectin DC-SIGN reveals an underestimated complexity 10.1042/BJ20050709
p-Hydroxybenzoic acid synthesis in Mycobacterium tuberculosis 10.1074/jbc.M508332200
Reduced local growth and spread but preserved pathogenicity of a DeltapurC Mycobacterium tuberculosis auxotrophic mutant in gamma interferon receptor-deficient mice after aerosol infection 10.1128/IAI.73.1.666-670.2005
Production of phthiocerol dimycocerosates protects Mycobacterium tuberculosis from the cidal activity of reactive nitrogen intermediates produced by macrophages and modulates the early immune response to infection 10.1046/j.1462-5822.2004.00368.x
Taxonomic characterization of nine strains isolated from clinical and environmental specimens, and proposal of Corynebacterium tuberculostearicum sp nov. 10.1099/ijs.0.02907-0
DC-SIGN is the major Mycobacterium tuberculosis receptor on human dendritic cells 10.1084/jem.20021468
Deficiency in mycolipenate- and mycosanoate-derived acyltrehaloses enhances early interactions of Mycobacterium tuberculosis with host cells 10.1046/j.1462-5822.2003.00289.x
Identification of the required acyltransferase step in the biosynthesis of the phosphatidylinositol mannosides of Mycobacterium species 10.1074/jbc.M303639200
Sulfolipid deficiency does not affect the virulence of Mycobacterium tuberculosis H37Rv in mice and guinea pigs 10.1128/IAI.71.8.4684-4690.2003
The cell surface receptor DC-SIGN discriminates between Mycobacterium species through selective recognition of the mannose caps on lipoarabinomannan 10.1074/jbc.C200586200
Unique mechanism of action of the thiourea drug isoxyl on Mycobacterium tuberculosis 10.1074/jbc.M311209200
Virulence attenuation of two Mas-like polyketide synthase mutants of Mycobacterium tuberculosis 10.1099/mic.0.26278-0
Definition of the first mannosylation step in phosphatidylinositol mannoside synthesis - PimA is essential for growth of mycobacteria 10.1074/jbc.M204060200
Phospholipases C are involved in the virulence of Mycobacterium tuberculosis 10.1046/j.1365-2958.2002.03009.x
Transient requirement of the PrrA-PrrB two-component system for early intracellular multiplication of Mycobacterium tuberculosis 10.1128/IAI.70.5.2256-2263.2002
Cell wall core galactofuran synthesis is essential for growth of mycobacteria 10.1128/JB.183.13.3991-3998.2001
Phosphatidylinositol is an essential phospholipid of mycobacteria 10.1074/jbc.M004658200
Inactivation of the antigen 85C gene profoundly affects the mycolate content and alters the permeability of the Mycobacterium tuberculosis cell envelope 10.1046/j.1365-2958.1999.01310.x
Efficient allelic exchange and transposon mutagenesis in Mycobacterium tuberculosis 10.1073/pnas.94.20.10955
Disinfectant Susceptibility Profiling of Glutaraldehyde-Resistant Nontuberculous Mycobacteria 10.1017/ice.2017.75
Design, synthesis and evaluation of indole-2-carboxamides with pan anti-mycobacterial activity 10.1016/j.bmc.2017.05.015
Mycobacterium bovis hosted by free-living-amoebae permits their long-term persistence survival outside of host mammalian cells and remain capable of transmitting disease to mice 10.1111/1462-2920.13810
Green Fluorescent Protein as a protein localization and topological reporter in mycobacteria 10.1016/j.tube.2017.04.001
2-aminoimidazoles potentiate ß-lactam antimicrobial activity against Mycobacterium tuberculosis by reducing ß-lactamase secretion and increasing cell envelope permeability 10.1371/journal.pone.0180925
HLA-E Presents Glycopeptides from the Mycobacterium tuberculosis Protein MPT32 to Human CD8(+) T cells 10.1038/s41598-017-04894-0
Mycobacterium talmoniae sp. nov., a slowly growing mycobacterium isolated from human respiratory samples 10.1099/ijsem.0.001998
Mycobacterium tuberculosis is protected from NADPH oxidase and LC3-associated phagocytosis by the LCP protein CpsA 10.1073/pnas.1707792114
Yersinia pestis Survival and Replication in Potential Ameba Reservoir 10.3201/eid2402.171065
Covalent modifications of polysaccharides in mycobacteria 10.1038/nchembio.2571
Impact of the epoxide hydrolase EphD on the metabolism of mycolic acids in mycobacteria 10.1074/jbc.RA117.000246
Cytokinin Signaling in Mycobacterium tuberculosis 10.1128/mBio.00989-18
Evidence of zoonotic leprosy in Pará, Brazilian Amazon, and risks associated with human contact or consumption of armadillos 10.1371/journal.pntd.0006532
Optimization and Lead Selection of Benzothiazole Amide Analogs Toward a Novel Antimycobacterial Agent 10.3389/fmicb.2018.02231
Advancing Translational Science for Pulmonary NTM Infections: A Roadmap for Research. 10.1164/rccm.201807-1273PP
Deciphering the molecular basis of mycobacteria and lipoglycan recognition by the C-type lectin Dectin-2 10.1038/s41598-018-35393-5
Disruption of the SucT acyltransferase in Mycobacterium smegmatis abrogates succinylation of cell envelope polysaccharides 10.1074/jbc.ra119.008585
Direct Inhibition of MmpL3 by Novel Antitubercular Compounds 10.1021/acsinfecdis.9b00048
Characterization of Arabinosyl Transfer Reactions in the Biosynthesis of Mycobacterial Cell Envelope (Lipo)Polysaccharides 10.1007/978-1-4939-9154-9_14
2-aminoimidazoles collapse mycobacterial proton motive force and block the electron transport chain 10.1038/s41598-018-38064-7
Indole-2-Carboxamides Are Active against Mycobacterium abscessus in a Mouse Model of Acute Infection 10.1128/aac.02245-18
Primary Lung Dendritic Cell Cultures to Assess Efficacy of Spectinamide-1599 Against Intracellular Mycobacterium tuberculosis 10.3389/fmicb.2018.01895
The MmpL3 interactome reveals a complex crosstalk between cell envelope biosynthesis and cell elongation and division in mycobacteria 10.1038/S41598-019-47159-8
New Approaches to Target the Mycolic Acid Biosynthesis Pathway for the Development of Tuberculosis Therapeutics 10.2174/1381612819666131118203641
Identification of serological biomarkers of infection, disease progression and treatment efficacy for leprosy 10.1590/S0074-02762012000900014
Structure, Biosynthesis, and Activities of the Phosphatidyl-myo-Inositol-Based Lipoglycans 10.1128/9781555815783.CH6
The Mycobacterium tuberculosis purine biosynthetic pathway: Isolation and characterization of the purC and purL genes 10.1099/00221287-142-9-2439
MmpL3 as a Target for the Treatment of Drug-Resistant Nontuberculous Mycobacterial Infections 10.3389/FMICB.2018.01547
Mycobacterium tuberculosis Des protein: An immunodominant target for the humoral response of tuberculous patients 10.1128/IAI.65.7.2883-2889.1997
Interactions of free-living amoebae with rice bacterial pathogens Xanthomonas oryzae pathovars oryzae and oryzicola 10.1371/JOURNAL.PONE.0202941
Mobile genetic elements and plasmids: tools for genetic studies 10.1002/9781444311433.CH2
Biochemical and microbiological evaluation of N-aryl urea derivatives against mycobacteria and mycobacterial hydrolases 10.1039/C9MD00122K
Identification of New MmpL3 Inhibitors by Untargeted and Targeted Mutant Screens Defines MmpL3 Domains with Differential Resistance 10.1128/AAC.00547-19
Mechanisms of Resistance Associated with the Inhibition of the Dehydration Step of Type II Fatty Acid Synthase in Mycobacterium tuberculosis 10.1021/ACSINFECDIS.9B00162
Interactions of free-living amoebae with the rice fungal pathogen, Rhizoctonia solani 10.1186/S13104-019-4802-2
Analysing nonsynonymous mutations between two Mycobacterium bovis strains with contrasting pathogenic profiles 10.1016/J.VETMIC.2019.108482
Cloning and Partial Characterization of an Endo-alpha-(1 -> 6)-D-Mannanase Gene from Bacillus circulans 10.3390/IJMS20246244
Efficient method for targeted gene disruption by homologous recombination in Mycobacterium avium subspecie paratuberculosis 10.1016/J.RESMIC.2020.04.001
Busting biofilms: free-living amoebae disrupt preformed methicillin-resistant Staphylococcus aureus (MRSA) and Mycobacterium bovis biofilms 10.1099/MIC.0.000933
Potency Increase of Spiroketal Analogs of Membrane Inserting Indolyl Mannich Base Antimycobacterials Is Due to Acquisition of MmpL3 Inhibition 10.1021/ACSINFECDIS.0C00121
Cell Surface Remodeling of Mycobacterium abscessus under Cystic Fibrosis Airway Growth Conditions 10.1021/ACSINFECDIS.0C00214
Polysaccharide Succinylation Enhances the Intracellular Survival of Mycobacterium abscessus 10.1021/ACSINFECDIS.0C00361
Fragment-based discovery of a new class of inhibitors targeting mycobacterial tRNA modification 10.1093/NAR/GKAA539
Secondary extended mannan side chains and attachment of the arabinan in mycobacterial lipoarabinomannan 10.1038/S42004-020-00356-3
MmpL3 Inhibition: A New Approach to Treat Nontuberculous Mycobacterial Infections 10.3390/IJMS21176202
Lack of Specificity of Phenotypic Screens for Inhibitors of the Mycobacterium tuberculosis FAS-II System 10.1128/AAC.01914-20
Transporters Involved in the Biogenesis and Functionalization of the Mycobacterial Cell Envelope 10.1021/ACS.CHEMREV.0C00869
Two-Way Regulation of MmpL3 Expression Identifies and Validates Inhibitors of MmpL3 Function in Mycobacterium tuberculosis 10.1021/ACSINFECDIS.0C00675
Use of Synthetic Glycolipids to Probe the Number and Position of Arabinan Chains on Mycobacterial Arabinogalactan 10.1021/ACSCHEMBIO.0C00765
A Coumarin-Based Analogue of Thiacetazone as Dual Covalent Inhibitor and Potential Fluorescent Label of HadA in Mycobacterium tuberculosis 10.1021/ACSINFECDIS.0C00325
Mycobacterial Epoxide Hydrolase EphD Is Inhibited by Urea and Thiourea Derivatives 10.3390/IJMS22062884
Pipeline of anti-Mycobacterium abscessus small molecules: Repurposable drugs and promising novel chemical entities 10.1002/MED.21798
Role of PhoPR in the response to stress of Mycobacterium bovis 10.1016/J.CIMID.2020.101593
Stepwise pathogenic evolution of Mycobacterium abscessus 10.1126/SCIENCE.ABB8699
Identification and functional analysis of a galactosyltransferase capable of cholesterol glycolipid formation in the Lyme disease spirochete Borrelia burgdorferi 10.1371/JOURNAL.PONE.0252214
A Model of action for peripheral Membrane-Associated GT-B Glycosyltransferases 10.1107/S010876731108799X
Structural basis of methylglucose lipopolysaccharide biosynthesis in mycobacteria 10.1107/S0108767311080019
Transcriptional adaptation of Mycobacterium ulcerans in an original mouse model: New insights into the regulation of mycolactone 10.1080/21505594.2021.1929749
Increased Virulence of Outer Membrane Porin Mutants of Mycobacterium abscessus 10.3389/FMICB.2021.706207
Identifying Bacterial and Host Factors Involved in the Interaction of Mycobacterium bovis with the Bovine Innate Immune Cells 10.3389/FIMMU.2021.674643
An antitubercular prodrug leaves Mycobacterium tuberculosis facing a difficult choice, poisoning or starvation? 10.1016/J.CHEMBIOL.2021.07.019
S16 and T18 mannosylation sites of LppX are not essential for its activity in phthiocerol dimycocerosates localization at the surface of Mycobacterium tuberculosis 10.1016/J.RESMIC.2021.103874
Priscille Brodin
Brodin Priscille
ORCID: 0000-0003-0991-7344
Email: priscille.brodin@inserm.fr
How can nanoparticles contribute to antituberculosis therapy? 10.1016/j.drudis.2017.01.011
Host-directed therapies offer novel opportunities for the fight against tuberculosis 10.1016/j.drudis.2017.05.005
A Bacterial Toxin with Analgesic Properties: Hyperpolarization of DRG Neurons by Mycolactone 10.3390/toxins9070227
A Bacterial Toxin with Analgesic Properties: Hyperpolarization of DRG Neurons by Mycolactone 10.3390/toxins9070227 10.3390/toxins9070227.
Clofazimine encapsulation in nanoporous silica particles for the oral treatment of antibiotic-resistant Mycobacterium tuberculosis infections 10.2217/nnm-2016-0364
Cyclodextrin-based nanocarriers containing a synergic drug combination: a potential formulation for pulmonary administration of antitubercular drugs 10.1016/j.ijpharm.2017.05.030 10.1016/j.ijpharm.2017.05.030.
Genome-wide, high-content siRNA screening identifies the Alzheimer's genetic risk factor FERMT2 as a major modulator of APP metabolism 10.1007/s00401-016-1652-z
Host-directed therapies offer novel opportunities for the fight against tuberculosis 10.1016/j.drudis.2017.05.005 10.1016/j.drudis.2017.05.005.
Identification of aminopyrimidine-sulfonamides as potent modulators of Wag31-mediated cell elongation in mycobacteria 10.1111/mmi.13535
Impact of pe_ pgrs33 Gene Polymorphisms on Mycobacterium tuberculosis Infection and Pathogenesis 10.3389/fcimb.2017.00137
LppM impact on the colonization of macrophages by Mycobacterium tuberculosis 10.1111/cmi.12619
Phenotypic assays for Mycobacterium tuberculosis infection 10.1002/cyto.a.23129 10.1002/cyto.a.23129.
Reversion of antibiotic resistance in Mycobacterium tuberculosis by spiroisoxazoline SMARt-420 10.1126/science.aag1006
A fragment merging approach towards the development of small molecule inhibitors of Mycobacterium tuberculosis EthR for use as ethionamide boosters 10.1039/c5ob02630j
Khaya grandifoliola C.DC: a potential source of active ingredients against hepatitis C virus in vitro 10.1007/s00705-016-2771-5
Mycobacterium tuberculosis LppM Displays an Original Structure and Domain Composition Linked to a Dual Localization 10.1016/j.str.2016.07.009
Mycolactone The amazing analgesic mycobacterial toxin 10.1051/medsci/20163202007
STAT3 Represses Nitric Oxide Synthesis in Human Macrophages upon Mycobacterium tuberculosis Infection 10.1038/srep29297
2-Carboxyquinoxalines Kill Mycobacterium tuberculosis through Noncovalent Inhibition of DprE1 10.1021/cb5007163
Cytosolic Access of Mycobacterium tuberculosis: Critical Impact of Phagosomal Acidification Control and Demonstration of Occurrence In Vivo 10.1371/journal.ppat.1004650
High content screening in chemical biology: overview and main challenges 10.1051/medsci/20153102016
High-Content Screening Technology Combined with a Human Granuloma Model as a New Approach To Evaluate the Activities of Drugs against Mycobacterium tuberculosis 10.1128/aac.03705-14
Increased protective efficacy of recombinant BCG strains expressing virulence-neutral proteins of the ESX-1 secretion system 10.1016/j.vaccine.2015.03.083
Plant extracts from Cameroonian medicinal plants strongly inhibit hepatitis C virus infection in vitro 10.3389/fmicb.2015.00438
Polyphenols Inhibit Hepatitis C Virus Entry by a New Mechanism of Action 10.1128/jvi.01473-15
Testing chemical and genetic Modulators in Mycobacterium tuberculosis infected cells using phenotypic assays 10.1007/978-1-4939-2450-9_24
A Microscopic Phenotypic Assay for the Quantification of Intracellular Mycobacteria Adapted for High-throughput/High-content Screening 10.3791/51114
Ligand Efficiency Driven Design of New Inhibitors of Mycobacterium tuberculosis Transcriptional Repressor EthR Using Fragment Growing, Merging, and Linking Approaches 10.1021/jm500422b
Mycobacterial Toxin Induces Analgesia in Buruli Ulcer by Targeting the Angiotensin Pathways 10.1016/j.cell.2014.04.040
Potent antiviral activity of Solanum rantonnetii and the isolated compounds against hepatitis C virus in vitro 10.1016/j.jff.2014.09.022
A novel specific edge effect correction method for RNA interference screenings 10.1093/bioinformatics/btr648
Discovery of Novel N-Phenylphenoxyacetamide Derivatives as EthR Inhibitors and Ethionamide Boosters by Combining High-Throughput Screening and Synthesis 10.1021/jm3003779
Ethionamide Boosters. 2. Combining Bioisosteric Replacement and Structure-Based Drug Design To Solve Pharmacokinetic Issues in a Series of Potent 1,2,4-Oxadiazole EthR Inhibitors 10.1021/jm200825u
The Balance of Apoptotic and Necrotic Cell Death in Mycobacterium tuberculosis Infected Macrophages Is Not Dependent on Bacterial Virulence 10.1371/journal.pone.0047573
Analogous Mechanisms of Resistance to Benzothiazinones and Dinitrobenzamides in Mycobacterium smegmatis 10.1371/journal.pone.0026675
Ethionamide Boosters: Synthesis, Biological Activity, and Structure-Activity Relationships of a Series of 1,2,4-Oxadiazole EthR Inhibitors 10.1021/jm200076a
High-content screening in infectious diseases 10.1016/j.cbpa.2011.05.023
Functional characterization of the Mycobacterium tuberculosis serine/threonine kinase PknJ 10.1099/mic.0.038133-0
High Content Phenotypic Cell-Based Visual Screen Identifies Mycobacterium tuberculosis Acyltrehalose-Containing Glycolipids Involved in Phagosome Remodeling 10.1371/journal.ppat.1001100
High-content imaging of Mycobacterium tuberculosis-infected macrophages: an in vitro model for tuberculosis drug discovery 10.4155/fmc.10.223
Long-circulating DNA lipid nanocapsules as new vector for passive tumor targeting 10.1016/j.biomaterials.2009.09.044
Automated High-Throughput siRNA Transfection in Raw 264.7 Macrophages: A Case Study for Optimization Procedure 10.1177/1087057108328762
Benzothiazinones Kill Mycobacterium tuberculosis by Blocking Arabinan Synthesis 10.1126/science.1171583
High Content Screening Identifies Decaprenyl-Phosphoribose 2 ' Epimerase as a Target for Intracellular Antimycobacterial Inhibitors 10.1371/journal.ppat.1000645
Systematic Genetic Nomenclature for Type VII Secretion Systems 10.1371/journal.ppat.1000507
Control of M-tuberculosis ESAT-6 secretion and specific T cell recognition by PhoP 10.1371/journal.ppat.0040033
Aquatic insects and transmission of Mycobacterium ulcerans 10.1051/medsci/20072367572
ESAT-6 from Mycobacterium tuberculosis dissociates from its putative chaperone CFP-10 under acidic conditions and exhibits membrane-lysing activity 10.1128/jb.00469-07
Impact of Mycobacterium ulcerans biofilm on transmissibility to ecological niches and Buruli ulcer pathogenesis 10.1371/journal.ppat.0030062
Protection against mycobacterium ulcerans lesion development by exposure to aquatic insect saliva 10.1371/journal.pmed.0040064
Support vector machines for automatic detection of tuberculosis bacteria in confocal microscopy images 10.1109/isbi.2007.356794
Synthesis and antimycobacterial evaluation of benzofurobenzopyran analogues 10.1016/j.bmc.2006.12.009
An increase in antimycobacterial Th1-cell responses by prime-boost protocols of immunization does not enhance protection against tuberculosis 10.1128/iai.74.4.2128-2137.2006
Benzofuro 3,2-f 1 benzopyrans: A new class of antitubercular agents 10.1016/j.bmc.2006.03.033
Dissection of ESAT-6 system 1 of Mycobacterium tuberculosis and impact on immunogenicity and virulence 10.1128/iai.74.1.88-98.2006
High frequency of CD4(+) T cells specific for the TB10.4 protein correlates with protection against Mycobacterium tuberculosis infection 10.1128/iai.02086-05
Inactivation of Rv2525c, a substrate of the twin arginine translocation (Tat) system of Mycobacterium tuberculosis, increases beta-lactam susceptibility and virulence 10.1128/jb.00631-06
Evaluation of vaccines in the EU TB vaccine cluster using a guinea pig aerosol infection model of tuberculosis 10.1016/j.tube.2004.09.009
Functional analysis of early secreted antigenic target-6, the dominant T-cell antigen of Mycobacterium tuberculosis, reveals key residues involved in secretion, complex formation, virulence, and immunogenicity 10.1074/jbc.M503515200
Immunogenic membrane-associated proteins of Mycobacterium tuberculosis revealed by proteomics 10.1099/mic.0.27799-0
Proteomic identification of M. tuberculosis protein kinase substrates: PknB recruits GarA, a FHA domain-containing protein, through activation loop-mediated interactions 10.1016/j.jmb.2005.05.049
Tuberculosis: from genome to vaccine 10.1586/14760584.4.4.541
Cell envelope protein PPE68 contributes to Mycobacterium tuberculosis RDI immunogenicity independently of a 10-kilodalton culture filtrate protein and ESAT-6 10.1128/iai.72.4.2170-2176.2004
Enhanced protection against tuberculosis by vaccination with recombinant Mycobacterium microti vaccine that induces T cell immunity against region of difference 1 antigens 10.1086/421468
ESAT-6 proteins: protective antigens and virulence factors? 10.1016/j.tim.2004.09.007
Macro-array and bioinformatic analyses reveal mycobacterial 'core' genes, variation in the ESAT-6 gene family and new phylogenetic markers for the Mycobacterium tuberculosis complex 10.1099/mic.0.26662-0
CD8(+)-T-cell responses of mycobacterium-infected mice to a newly identified major histocompatibility complex class I-restricted epitope shared by proteins of the ESAT-6 family 10.1128/iai.71.12.7173-7177.2003
Recombinant BCG exporting ESAT-6 confers enhanced protection against tuberculosis 10.1038/nm859
A new evolutionary scenario for the Mycobacterium tuberculosis complex 10.1073/pnas.052548299
Bacterial artificial chromosome-based comparative genomic analysis identifies Mycobacterium microti as a natural ESAT-6 deletion mutant 10.1128/iai.70.10.5568-5578.2002
Disruption of HIV-1 integrase-DNA complexes by short 6-oxocytosine-containing oligonucleotides 10.1021/bi015732y
Loss of RD1 contributed to the attenuation of the live tuberculosis vaccines Mycobacterium bovis BCG and Mycobacterium microti 10.1046/j.1365-2958.2002.03237.x
6-Oxocytidine containing oligonucleotides inhibit the HIV-1 integrase in vitro 10.1081/ncn-100002322
Determinants of Mg2+-dependent activities of recombinant human immunodeficiency virus type 1 integrase 10.1021/bi000398b
Inhibition of the human immunodeficiency virus type 1 DNA integration by modified oligonucleotides 10.1023/a:1026631910681
Branched oligonucleotide-intercalator conjugate forming a parallel stranded structure inhibits HIV-1 integrase 10.1016/s0014-5793(99)01350-2
Inhibition of HIV-1 integration by mono- & bi-functionalized triple helix forming oligonucleotides 10.1080/07328319908044831
Optimization of alternate-strand triple helix formation at the 5 '-TpA-3 ' and 5 '-ApT-3 ' junctions 10.1093/nar/27.15.3029
A truncated HIV-1 Tat protein basic domain rapidly translocates through the plasma membrane and accumulates in the cell nucleus 10.1074/jbc.272.25.16010
Mycobacterium tuberculosis inhibits human innate immune responses via the production of TLR2 antagonist glycolipids 10.1073/pnas.1707840114
ArfGAP1 restricts Mycobacterium tuberculosis entry by controlling the actin cytoskeleton 10.15252/embr.201744371
ArfGAP1 restricts Mycobacterium tuberculosis entry by controlling the actin cytoskeleton 10.15252/embr.201744371 10.15252/embr.201744371.
Combination therapy for tuberculosis treatment: pulmonary administration of ethionamide and booster co-loaded nanoparticles 10.1038/s41598-017-05453-3
Cyclipostins and Cyclophostin analogs as promising compounds in the fight against tuberculosis 10.1038/s41598-017-11843-4 10.1038/s41598-017-11843-4.
Fragment-Sized EthR Inhibitors Exhibit Exceptionally Strong Ethionamide Boosting Effect in Whole-Cell Mycobacterium tuberculosis Assays 10.1021/acschembio.7b00091
Host-pathogen systems for early drug discovery against tuberculosis 10.1016/j.mib.2017.11.017 10.1016/j.mib.2017.11.017.
Legionella pneumophila Modulates Mitochondrial Dynamics to Trigger Metabolic Repurposing of Infected Macrophages 10.1016/j.chom.2017.07.020 10.1016/j.chom.2017.07.020. Epub 2017 Aug 31.
Mycobacterium tuberculosis Controls Phagosomal Acidification by Targeting CISH-Mediated Signaling 10.1016/j.celrep.2017.08.101 10.1016/j.celrep.2017.08.101.
Mycobacterium tuberculosis inhibits human innate immune responses via the production of TLR2 antagonist glycolipids 10.1073/pnas.1707840114 10.1073/pnas.1707840114.
Identification of Piperazinylbenzenesulfonamides as New Inhibitors of Claudin-1 Trafficking and Hepatitis C Virus Entry 10.1128/jvi.01982-17
Multiplexed Quantitation of Intraphagocyte Mycobacterium tuberculosis Secreted Protein Effectors 10.1016/j.celrep.2018.03.125
Oxadiazolone derivatives, new promising multi-target inhibitors against M. tuberculosis 10.1016/j.bioorg.2018.08.025
Proteomics of Mycobacterium infection: Moving towards a Better Understanding of Pathogen-Driven immunomodulation 10.3389/fimmu.2018.00086
Synergy between circular bacteriocin AS-48 and ethambutol against Mycobacterium tuberculosis 10.1128/aac.00359-18
The EU approved antimalarial pyronaridine shows antitubercular activity and synergy with rifampicin, targeting RNA polymerase 10.1016/j.tube.2018.08.004
Cyclipostins and Cyclophostin analogs as promising compounds in the fight against tuberculosis 10.1038/s41598-017-11843-4
Cyclodextrin-based nanocarriers containing a synergic drug combination: A potential formulation for pulmonary administration of antitubercular drugs 10.1016/j.ijpharm.2017.05.030
Host-pathogen systems for early drug discovery against tuberculosis 10.1016/j.mib.2017.11.017
Legionella pneumophila Modulates Mitochondrial Dynamics to Trigger Metabolic Repurposing of Infected Macrophages 10.1016/j.chom.2017.07.020
Mycobacterium tuberculosis Controls Phagosomal Acidification by Targeting CISH-Mediated Signaling 10.1016/j.celrep.2017.08.101
Phenotypic assays for Mycobacterium tuberculosis infection 10.1002/cyto.a.23129
A fast, fully automated cell segmentation algorithm for high-throughput and high-content screening 10.1002/cyto.a.20627
Compartmentalized Encapsulation of Two Antibiotics in Porous Nanoparticles: an Efficient Strategy to Treat Intracellular Infections 10.1002/ppsc.201800360
Spatiotemporal Changes of the Phagosomal Proteome in Dendritic Cells in Response to LPS Stimulation 10.1074/mcp.RA119.001316
Mycolactone as Analgesic: Subcutaneous Bioavailability Parameters 10.3389/fphar.2019.00378
Intrinsic Antibacterial Activity of Nanoparticles Made of β-Cyclodextrins Potentiates Their Effect as Drug Nanocarriers against Tuberculosis 10.1021/acsnano.8b07902
Mitochondrial Dynamics and Activity in Legionella-Infected Cells 10.1007/978-1-4939-9048-1_13
Heparin-Binding Hemagglutinin Adhesin (HBHA) Is Involved in Intracytosolic Lipid Inclusions Formation in Mycobacteria 10.3389/fmicb.2018.02258
Dehydrojuncusol, a Natural Phenanthrene Compound Extracted from Juncus maritimus, Is a New Inhibitor of Hepatitis C Virus RNA Replication 10.1128/jvi.02009-18
A novel codrug made of the combination of ethionamide and its potentiating booster: synthesis, self-assembly into nanoparticles and antimycobacterial evaluation 10.1039/C9OB00680J
Could Mycolactone Inspire New Potent Analgesics? Perspectives and Pitfalls 10.3390/toxins11090516
Paradoxical Roles of the MAL/Tirap Adaptor in Pathologies. 10.3389/fimmu.2020.569127
Fragment-Based Optimized EthR Inhibitors with in Vivo Ethionamide Boosting Activity. 10.1021/acsinfecdis.9b00277
Intracellular and in vivo evaluation of imidazo[2,1-b]thiazole-5-carboxamide anti-tuberculosis compounds. 10.1371/journal.pone.0227224
Preclinical assessment of a new live attenuated Mycobacterium tuberculosis Beijing-based vaccine for tuberculosis. 10.1016/j.vaccine.2019.11.085
IRG1 controls immunometabolic host response and restricts intracellular Mycobacterium tuberculosis infection 10.1101/761551
Worms' Antimicrobial Peptides. 10.3390/md17090512
Theaflavins, polyphenols of black tea, inhibit entry of hepatitis C virus in cell culture. 10.1371/journal.pone.0198226
Plant extracts from Cameroonian medicinal plants strongly inhibit hepatitis C virus infection in vitro. 10.3389/fmicb.2015.00488
Discovery of Q203, a potent clinical candidate for the treatment of tuberculosis. 10.1038/nm.3262
Discovery of novel N-phenylphenoxyacetamide derivatives as EthR inhibitors and ethionamide boosters by combining high-throughput screening and synthesis. 10.1021/jm300377g
Shortening the drug discovery pipeline: small molecule high content screening for lead discovery in neglected disease. 10.1186/1753-6561-5-s1-p38
Automated HTS/HCS for antivirals using visual HIV full replication assays. 10.1186/1742-4690-6-s2-p82
Influence of ESAT-6 secretion system 1 (RD1) of Mycobacterium tuberculosis on the interaction between mycobacteria and the host immune system. 10.4049/jimmunol.174.6.3570
Cell microbiology interview 10.1111/cmi.13288
Pathogenomic analyses of Mycobacterium microti, an ESX-1-deleted member of the Mycobacterium tuberculosis complex causing disease in various hosts 10.1099/mgen.0.000505
Pablo Bifani
Bifani Pablo
ORCID: 0000-0001-9651-6439
Worldwide Occurrence of Beijing/W Strains ofMycobacterium tuberculosis: A Systematic Review 10.3201/eid0808.020002
Identification of a W Variant Outbreak of Mycobacterium tuberculosis via Population-Based Molecular Epidemiology 10.1001/jama.282.24.2321
Strain families of Mycobacterium tuberculosis 10.1016/s0966-842x(02)02318-1
Origin and Interstate Spread of a New York City Multidrug-Resistant Mycobacterium tuberculosis Clone Family 10.1001/jama.1996.03530300036037
Global dissemination of the Mycobacterium tuberculosis W-Beijing family strains 10.1016/s0966-842x(01)02277-6
Worldwide Occurrence of Beijing/W Strains ofMycobacterium tuberculosis: A Systematic Review 10.3201/eid0805.020002
Genomic Epidemiology of Lineage 4 Mycobacterium tuberculosis Subpopulations in New York City and New Jersey, 1999–2009 10.1093/ofid/ofw172.417
Identification and structural characterization of an unusual mycobacterial monomeromycolyl-diacylglycerol 10.1111/j.1365-2958.2005.04717.x
Molecular Epidemiology of Multidrug-Resistant Tuberculosis, New York City, 1995–1997 10.3201/eid0811.020288
BCG Induces Protection against Mycobacterium tuberculosis Infection in the Wistar Rat Model 10.1371/journal.pone.0028082
Enhanced bacterial virulence through exploitation of host glycosaminoglycans 10.1046/j.1365-2958.2002.02841.x
Detecting the molecular scars of evolution in the Mycobacterium tuberculosis complex by analyzing interrupted coding sequences 10.1186/1471-2148-8-78
A novel and more sensitive loop-mediated isothermal amplification assay targeting IS6110 for detection of Mycobacterium tuberculosis complex 10.1016/j.micres.2009.05.001
Identification and Evolution of an IS6110Low‐Copy‐NumberMycobacterium tuberculosisCluster 10.1086/339345
Nosocomial Transmission of a Drug-Sensitive W-Variant Mycobacterium tuberculosis Strain among Patients with Acquired Immunodeficiency Syndrome in Tennessee 10.1086/647889
Mutations in Putative Mutator Genes ofMycobacterium tuberculosisStrains of the W-Beijing Family 10.3201/eid0907.020803
Exploring the Mode of Action of Bioactive Compounds by Microfluidic Transcriptional Profiling in Mycobacteria 10.1371/journal.pone.0069191
Characterization of a putative α-mannosyltransferase involved in phosphatidylinositol trimannoside biosynthesis in Mycobacterium tuberculosis 10.1042/bj3630437
Persistence of a Highly Resistant Strain of Tuberculosis in New York City during 1990–1999 10.1086/376837
Increased Vancomycin Susceptibility in Mycobacteria: a New Approach To Identify Synergistic Activity against Multidrug-Resistant Mycobacteria 10.1128/aac.04856-14
Nosocomial Transmission of a Drug-Sensitive W-Variant Mycobacterium tuberculosis Strain among Patients with Acquired Immunodeficiency Syndrome in Tennessee 10.2307/30141525
Structural basis of mapping the spontaneous mutations with 5-flurouracil in uracil phosphoribosyltransferase from Mycobacterium tuberculosis 10.1016/j.bbrc.2015.09.133
Molecular evidence suggestive of intrauterine transmission of Neisseria meningitidis serogroup A from mother to infant 10.1055/s-0035-1557014
Synthetic EthR inhibitors boost antituberculous activity of ethionamide 10.1038/nm.1950
Characterization of a putative α-mannosyltransferase involved in phosphatidylinositol trimannoside biosynthesis in Mycobacterium tuberculosis 10.1042/0264-6021:3630437
The nature and consequence of genetic variability within Mycobacterium tuberculosis 10.1172/jci11426
Origin and interstate spread of a New York City multidrug-resistant Mycobacterium tuberculosis clone family 10.1001/jama.275.6.452
Standardised PCR-based molecular epidemiology of tuberculosis 10.1183/09031936.00053307
La PCR en temps réel : principe et application en infectiologie 10.1016/s1294-5501(07)91380-1
Molecular Epidemiology of Tuberculosis: Current Insights 10.1128/cmr.00061-05
A High-Throughput Screen To Identify Inhibitors of ATP Homeostasis in Non-replicatingMycobacterium tuberculosis 10.1021/cb2004884
Corrrection to Discovery of Tetrahydropyrazolopyrimidine Carboxamide Derivatives As Potent and Orally Active Novel Antitubercular Agents 10.1021/ml500020r
Experimental Tuberculosis in the Wistar Rat: A Model for Protective Immunity and Control of Infection 10.1371/journal.pone.0018632
Mutations in Genes for the F420Biosynthetic Pathway and a Nitroreductase Enzyme Are the Primary Resistance Determinants in SpontaneousIn Vitro-Selected PA-824-Resistant Mutants of Mycobacterium tuberculosis 10.1128/aac.00308-15
CC8 MRSA Strains Harboring SCCmec Type IVc are Predominant in Colombian Hospitals 10.1371/journal.pone.0038576
The Evolution of Drug Resistance inMycobacterium tuberculosis:From a Mono–Rifampin‐Resistant Cluster into Increasingly Multidrug‐Resistant Variants in an HIV‐Seropositive Population 10.1086/588822
Design, Synthesis, and Biological Evaluation of Indole-2-carboxamides: A Promising Class of Antituberculosis Agents 10.1021/jm4012774
UDP-galactose and acetyl-CoA transporters as Plasmodium multidrug resistance genes 10.1038/nmicrobiol.2016.166
Genomic analysis and growth characteristic of dengue viruses from Makassar, Indonesia 10.1016/j.meegid.2015.03.006
Additional file 3: of Genomic epidemiology of Lineage 4 Mycobacterium tuberculosis subpopulations in New York City and New Jersey, 1999â 2009 10.6084/M9.FIGSHARE.C.3617909_D1
The Plasmodium PI(4)K inhibitor KDU691 selectively inhibits dihydroartemisinin-pretreated Plasmodium falciparum ring-stage parasites. 10.1038/s41598-017-02440-6
Genomic epidemiology of Lineage 4 Mycobacterium tuberculosis subpopulations in New York City and New Jersey, 1999-2009. 10.1186/s12864-016-3298-6
Mutations in the Plasmodium falciparum Cyclic Amine Resistance Locus (PfCARL) Confer Multidrug Resistance. 10.1128/mbio.00696-16
Structure and mapping of spontaneous mutational sites of PyrR from Mycobacterium tuberculosis. 10.1016/j.bbrc.2016.02.071
Indolcarboxamide is a preclinical candidate for treating multidrug-resistant tuberculosis. 10.1126/scitranslmed.3007355
Discovery of Q203, a potent clinical candidate for the treatment of tuberculosis. 10.1038/nm.3262
para-Aminosalicylic acid is a prodrug targeting dihydrofolate reductase in Mycobacterium tuberculosis. 10.1074/jbc.m113.475798
Discovery of tetrahydropyrazolopyrimidine carboxamide derivatives as potent and orally active antitubercular agents. 10.1021/ml400071a
Heterogeneity of Mycobacterium tuberculosis strains in Makassar, Indonesia. 10.5588/ijtld.12.0055
Systematic analysis of pyrazinamide-resistant spontaneous mutants and clinical isolates of Mycobacterium tuberculosis. 10.1128/aac.05385-11
Epidemiologic consequences of microvariation in Mycobacterium tuberculosis. 10.1093/infdis/jir876
Mycobacterium tuberculosis infection induces hypoxic lung lesions in the rat. 10.1016/j.tube.2011.05.003
T cell monitoring of chemotherapy in experimental rat tuberculosis. 10.1128/aac.00136-11
Extremely high prevalence of multidrug resistant tuberculosis in Murmansk, Russia: a population-based study. 10.1007/s10096-011-1200-7
Phylogeny of Mycobacterium tuberculosis Beijing strains constructed from polymorphisms in genes involved in DNA replication, recombination and repair. 10.1371/journal.pone.0016020
Biochemical and immunological characterization of a cpn60.1 knockout mutant of Mycobacterium bovis BCG. 10.1099/mic.0.045120-0
A chemical genetic screen in Mycobacterium tuberculosis identifies carbon-source-dependent growth inhibitors devoid of in vivo efficacy. 10.1038/ncomms1060
Variable-number tandem repeat 3690 polymorphism in Indian clinical isolates of Mycobacterium tuberculosis and its influence on transcription. 10.1099/jmm.0.002550-0
Molecular genetics of para-aminosalicylic acid resistance in clinical isolates and spontaneous mutants of Mycobacterium tuberculosis. 10.1128/aac.01197-08
Genotyping of Mycobacterium tuberculosis clinical isolates using IS6110-based restriction fragment length polymorphism analysis. 10.1007/978-1-60327-999-4_14
IS1096-mediated DNA rearrangements play a key role in genome evolution of Mycobacterium smegmatis. 10.1016/j.tube.2008.02.003
Functional role of the PE domain and immunogenicity of the Mycobacterium tuberculosis triacylglycerol hydrolase LipY. 10.1128/iai.00410-07
Molecular and epidemiological evidence for spread of multiresistant methicillin-susceptible Staphylococcus aureus strains in hospitals. 10.1128/aac.01414-06
Proposal for standardization of optimized mycobacterial interspersed repetitive unit-variable-number tandem repeat typing of Mycobacterium tuberculosis. 10.1128/jcm.01392-06
Targeted hybridization of IS6110 fingerprints identifies the W-Beijing Mycobacterium tuberculosis strains among clinical isolates. 10.1128/jcm.43.5.2148-2154.2005
Immunological characterization of novel secreted antigens of Mycobacterium tuberculosis. 10.1111/j.0300-9475.2005.01557.x
Definition of the Beijing/W lineage of Mycobacterium tuberculosis on the basis of genetic markers. 10.1128/jcm.42.9.4040-4049.2004
Snapshot of moving and expanding clones of Mycobacterium tuberculosis and their global distribution assessed by spoligotyping in an international study. 10.1128/jcm.41.5.1963-1970.2003
Global distribution of Mycobacterium tuberculosis spoligotypes. 10.3201/eid0811.020125
Spoligologos: a bioinformatic approach to displaying and analyzing Mycobacterium tuberculosis data. 10.3201/eid0811.020174
Mycobacterial heparin-binding hemagglutinin and laminin-binding protein share antigenic methyllysines that confer resistance to proteolysis. 10.1073/pnas.162246899
Molecular identification of streptomycin monoresistant Mycobacterium tuberculosis related to multidrug-resistant W strain. 10.3201/eid0705.010512
Characterization of the secreted MPT53 antigen of Mycobacterium tuberculosis. 10.1128/iai.69.9.5936-5939.2001
Use of spoligotype analysis to detect laboratory cross-contamination. 10.1086/501799
MTSA-10, the product of the Rv3874 gene of Mycobacterium tuberculosis, elicits tuberculosis-specific, delayed-type hypersensitivity in guinea pigs. 10.1128/iai.68.2.990-993.2000
Characterization of the phylogenetic distribution and chromosomal insertion sites of five IS6110 elements in Mycobacterium tuberculosis: non-random integration in the dnaA-dnaN region. 10.1054/tuld.1998.0003
Quantitative Proteomic Analysis of Simian Primary Hepatocytes Reveals Candidate Molecular Markers for Permissiveness to Relapsing Malaria Plasmodium cynomolgi. 10.1002/pmic.201900021
Robust continuous in vitro culture of the Plasmodium cynomolgi erythrocytic stages. 10.1038/s41467-019-11332-4
Hepatic spheroids used as an in vitro model to study malaria relapse. 10.1016/j.biomaterials.2019.05.032
The Plasmodium liver-specific protein 2 (LISP2) is an early marker of liver stage development. 10.7554/eLife.43362
The addition of avibactam renders piperacillin an effective treatment for Mycobacterium abscessus infection in an in vivo model. 10.1186/s13756-018-0448-4
Imidazolopiperazines Kill both Rings and Dormant Rings in Wild-Type and K13 Artemisinin-Resistant Plasmodium falciparum In Vitro. 10.1128/AAC.02235-17
A comparative transcriptomic analysis of replicating and dormant liver stages of the relapsing malaria parasite Plasmodium cynomolgi. 10.7554/eLife.29605
Strict tropism for CD71+/CD234+ human reticulocytes limits the zoonotic potential of Plasmodium cynomolgi. 10.1182/blood-2017-02-764787
Nathalie deboosere
deboosere Nathalie
ORCID: 0000-0002-2873-5485
ArfGAP1 restricts Mycobacterium tuberculosis entry by controlling the actin cytoskeleton. 10.15252/embr.201744371
Mycobacterium tuberculosis Controls Phagosomal Acidification by Targeting CISH-Mediated Signaling. 10.1016/j.celrep.2017.08.101
A Bacterial Toxin with Analgesic Properties: Hyperpolarization of DRG Neurons by Mycolactone. 10.3390/toxins9070227
Phenotypic assays for Mycobacterium tuberculosis infection. 10.1002/cyto.a.23129
Fragment-Sized EthR Inhibitors Exhibit Exceptionally Strong Ethionamide Boosting Effect in Whole-Cell Mycobacterium tuberculosis Assays. 10.1021/acschembio.7b00091
STAT3 Represses Nitric Oxide Synthesis in Human Macrophages upon Mycobacterium tuberculosis Infection. 10.1038/srep29297
LppM impact on the colonization of macrophages by Mycobacterium tuberculosis. 10.1111/cmi.12619
A microscopic phenotypic assay for the quantification of intracellular mycobacteria adapted for high-throughput/high-content screening. 10.3791/51114
Adhesion of human pathogenic enteric viruses and surrogate viruses to inert and vegetal food surfaces. 10.1016/j.fm.2012.04.007
Viral elution and concentration method for detection of influenza A viruses in mud by real-time RT-PCR. 10.1016/j.jviromet.2011.10.013
Comparison of chlorine and peroxyacetic-based disinfectant to inactivate Feline calicivirus, Murine norovirus and Hepatitis A virus on lettuce. 10.1016/j.ijfoodmicro.2011.08.011
Direct detection of highly pathogenic avian influenza A/H5N1 virus from mud specimens. 10.1016/j.jviromet.2011.06.002
Development and validation of a concentration method for the detection of influenza a viruses from large volumes of surface water. 10.1128/aem.02484-10
A predictive microbiology approach for thermal inactivation of Hepatitis A virus in acidified berries. 10.1016/j.fm.2010.05.018
Assessment of the removal and inactivation of influenza viruses H5N1 and H1N1 by drinking water treatment. 10.1016/j.watres.2010.01.013
Intra-laboratory validation of a concentration method adapted for the enumeration of infectious F-specific RNA coliphage, enterovirus, and hepatitis A virus from inoculated leaves of salad vegetables. 10.1016/j.ijfoodmicro.2005.11.007
Modelling effect of physical and chemical parameters on heat inactivation kinetics of hepatitis A virus in a fruit model system. 10.1016/j.ijfoodmicro.2003.10.015
Host-pathogen systems for early drug discovery against tuberculosis. 10.1016/j.mib.2017.11.017
Mycobacterium tuberculosis inhibits human innate immune responses via the production of TLR2 antagonist glycolipids. 10.1073/pnas.1707840114
Cyclipostins and Cyclophostin analogs as promising compounds in the fight against tuberculosis. 10.1038/s41598-017-11843-4
Legionella pneumophila Modulates Mitochondrial Dynamics to Trigger Metabolic Repurposing of Infected Macrophages. 10.1016/j.chom.2017.07.020
Combination therapy for tuberculosis treatment: pulmonary administration of ethionamide and booster co-loaded nanoparticles. 10.1038/s41598-017-05453-3
Host-directed therapies offer novel opportunities for the fight against tuberculosis. 10.1016/j.drudis.2017.05.005
Cyclodextrin-based nanocarriers containing a synergic drug combination: A potential formulation for pulmonary administration of antitubercular drugs. 10.1016/j.ijpharm.2017.05.030
Impact of pe_pgrs33 Gene Polymorphisms on Mycobacterium tuberculosis Infection and Pathogenesis. 10.3389/fcimb.2017.00137
Clofazimine encapsulation in nanoporous silica particles for the oral treatment of antibiotic-resistant Mycobacterium tuberculosis infections. 10.2217/nnm-2016-0364
Reversion of antibiotic resistance in Mycobacterium tuberculosis by spiroisoxazoline SMARt-420. 10.1126/science.aag1006
How can nanoparticles contribute to antituberculosis therapy? 10.1016/j.drudis.2017.01.011
Genome-wide, high-content siRNA screening identifies the Alzheimer's genetic risk factor FERMT2 as a major modulator of APP metabolism. 10.1007/s00401-016-1652-z
Identification of aminopyrimidine-sulfonamides as potent modulators of Wag31-mediated cell elongation in mycobacteria. 10.1111/mmi.13535
Mycobacterium tuberculosis LppM Displays an Original Structure and Domain Composition Linked to a Dual Localization. 10.1016/j.str.2016.07.009
Khaya grandifoliola C.DC: a potential source of active ingredients against hepatitis C virus in vitro. 10.1007/s00705-016-2771-5
[Mycolactone: the amazing analgesic mycobacterial toxin]. 10.1051/medsci/20163202007
A fragment merging approach towards the development of small molecule inhibitors of Mycobacterium tuberculosis EthR for use as ethionamide boosters. 10.1039/c5ob02630j
Polyphenols Inhibit Hepatitis C Virus Entry by a New Mechanism of Action. 10.1128/jvi.01473-15
Plant extracts from Cameroonian medicinal plants strongly inhibit hepatitis C virus infection in vitro. 10.3389/fmicb.2015.00488
Increased protective efficacy of recombinant BCG strains expressing virulence-neutral proteins of the ESX-1 secretion system. 10.1016/j.vaccine.2015.03.083
Cytosolic access of Mycobacterium tuberculosis: critical impact of phagosomal acidification control and demonstration of occurrence in vivo. 10.1371/journal.ppat.1004650
[High content screening in chemical biology: overview and main challenges]. 10.1051/medsci/20153102016
Testing chemical and genetic Modulators in Mycobacterium tuberculosis infected cells using phenotypic assays. 10.1007/978-1-4939-2450-9_24
2-Carboxyquinoxalines kill mycobacterium tuberculosis through noncovalent inhibition of DprE1. 10.1021/cb5007163
High-content screening technology combined with a human granuloma model as a new approach to evaluate the activities of drugs against Mycobacterium tuberculosis. 10.1128/aac.03705-14
Mycobacterial toxin induces analgesia in buruli ulcer by targeting the angiotensin pathways. 10.1016/j.cell.2014.04.040
Ligand efficiency driven design of new inhibitors of Mycobacterium tuberculosis transcriptional repressor EthR using fragment growing, merging, and linking approaches. 10.1021/jm500422b
Discovery of Q203, a potent clinical candidate for the treatment of tuberculosis. 10.1038/nm.3262
The balance of apoptotic and necrotic cell death in Mycobacterium tuberculosis infected macrophages is not dependent on bacterial virulence. 10.1371/journal.pone.0047573
Discovery of novel N-phenylphenoxyacetamide derivatives as EthR inhibitors and ethionamide boosters by combining high-throughput screening and synthesis. 10.1021/jm300377g
Ethionamide boosters. 2. Combining bioisosteric replacement and structure-based drug design to solve pharmacokinetic issues in a series of potent 1,2,4-oxadiazole EthR inhibitors. 10.1021/jm200825u
A novel specific edge effect correction method for RNA interference screenings. 10.1093/bioinformatics/btr648
Analogous mechanisms of resistance to benzothiazinones and dinitrobenzamides in Mycobacterium smegmatis. 10.1371/journal.pone.0026675
High-content screening in infectious diseases. 10.1016/j.cbpa.2011.05.023
Ethionamide boosters: synthesis, biological activity, and structure-activity relationships of a series of 1,2,4-oxadiazole EthR inhibitors. 10.1021/jm200076a
Shortening the drug discovery pipeline: small molecule high content screening for lead discovery in neglected disease. 10.1186/1753-6561-5-s1-p38
High content phenotypic cell-based visual screen identifies Mycobacterium tuberculosis acyltrehalose-containing glycolipids involved in phagosome remodeling. 10.1371/journal.ppat.1001100
High-content imaging of Mycobacterium tuberculosis-infected macrophages: an in vitro model for tuberculosis drug discovery. 10.4155/fmc.10.223
Functional characterization of the Mycobacterium tuberculosis serine/threonine kinase PknJ. 10.1099/mic.0.038133-0
High content screening identifies decaprenyl-phosphoribose 2' epimerase as a target for intracellular antimycobacterial inhibitors. 10.1371/journal.ppat.1000645
Systematic genetic nomenclature for type VII secretion systems. 10.1371/journal.ppat.1000507
Long-circulating DNA lipid nanocapsules as new vector for passive tumor targeting. 10.1016/j.biomaterials.2009.09.044
Automated HTS/HCS for antivirals using visual HIV full replication assays. 10.1186/1742-4690-6-s2-p82
Benzothiazinones kill Mycobacterium tuberculosis by blocking arabinan synthesis. 10.1126/science.1171583
Automated high-throughput siRNA transfection in raw 264.7 macrophages: a case study for optimization procedure. 10.1177/1087057108328762
Control of M. tuberculosis ESAT-6 secretion and specific T cell recognition by PhoP. 10.1371/journal.ppat.0040033
ESAT-6 from Mycobacterium tuberculosis dissociates from its putative chaperone CFP-10 under acidic conditions and exhibits membrane-lysing activity. 10.1128/jb.00469-07
[Aquatic insects and transmission of Mycobacterium ulcerans]. 10.1051/medsci/20072367572
Impact of Mycobacterium ulcerans biofilm on transmissibility to ecological niches and Buruli ulcer pathogenesis. 10.1371/journal.ppat.0030062
Protection against Mycobacterium ulcerans lesion development by exposure to aquatic insect saliva. 10.1371/journal.pmed.0040064
Synthesis and antimycobacterial evaluation of benzofurobenzopyran analogues. 10.1016/j.bmc.2006.12.009
Inactivation of Rv2525c, a substrate of the twin arginine translocation (Tat) system of Mycobacterium tuberculosis, increases beta-lactam susceptibility and virulence. 10.1128/jb.00631-06
High frequency of CD4+ T cells specific for the TB10.4 protein correlates with protection against Mycobacterium tuberculosis infection. 10.1128/iai.02086-05
Benzofuro[3,2-f][1]benzopyrans: a new class of antitubercular agents. 10.1016/j.bmc.2006.03.033
An increase in antimycobacterial Th1-cell responses by prime-boost protocols of immunization does not enhance protection against tuberculosis. 10.1128/iai.74.4.2128-2137.2006
Dissection of ESAT-6 system 1 of Mycobacterium tuberculosis and impact on immunogenicity and virulence. 10.1128/iai.74.1.88-98.2006
Tuberculosis: from genome to vaccine. 10.1586/14760584.4.4.541
Functional analysis of early secreted antigenic target-6, the dominant T-cell antigen of Mycobacterium tuberculosis, reveals key residues involved in secretion, complex formation, virulence, and immunogenicity. 10.1074/jbc.m503515200
Immunogenic membrane-associated proteins of Mycobacterium tuberculosis revealed by proteomics. 10.1099/mic.0.27799-0
Influence of ESAT-6 secretion system 1 (RD1) of Mycobacterium tuberculosis on the interaction between mycobacteria and the host immune system. 10.4049/jimmunol.174.6.3570
Evaluation of vaccines in the EU TB Vaccine Cluster using a guinea pig aerosol infection model of tuberculosis. 10.1016/j.tube.2004.09.009
ESAT-6 proteins: protective antigens and virulence factors? 10.1016/j.tim.2004.09.007
Enhanced protection against tuberculosis by vaccination with recombinant Mycobacterium microti vaccine that induces T cell immunity against region of difference 1 antigens. 10.1086/421468
Cell envelope protein PPE68 contributes to Mycobacterium tuberculosis RD1 immunogenicity independently of a 10-kilodalton culture filtrate protein and ESAT-6. 10.1128/iai.72.4.2170-2176.2004
Macro-array and bioinformatic analyses reveal mycobacterial 'core' genes, variation in the ESAT-6 gene family and new phylogenetic markers for the Mycobacterium tuberculosis complex. 10.1099/mic.0.26662-0
CD8+-T-cell responses of Mycobacterium-infected mice to a newly identified major histocompatibility complex class I-restricted epitope shared by proteins of the ESAT-6 family. 10.1128/iai.71.12.7173-7177.2003
Recombinant BCG exporting ESAT-6 confers enhanced protection against tuberculosis. 10.1038/nm859
Loss of RD1 contributed to the attenuation of the live tuberculosis vaccines Mycobacterium bovis BCG and Mycobacterium microti. 10.1046/j.1365-2958.2002.03237.x
Bacterial artificial chromosome-based comparative genomic analysis identifies Mycobacterium microti as a natural ESAT-6 deletion mutant. 10.1128/iai.70.10.5568-5578.2002
Disruption of HIV-1 integrase-DNA complexes by short 6-oxocytosine-containing oligonucleotides. 10.1021/bi015732y
IRG1 controls immunometabolic host response and restricts intracellular Mycobacterium tuberculosis infection 10.1101/761551
Large scale screening discovers clofoctol as an inhibitor of SARS-CoV-2 replication that reduces COVID-19-like pathology 10.1101/2021.06.30.450483
Marie KEMPF
KEMPF Marie
ORCID: 0000-0002-2943-7500
Carbapenem resistance and Acinetobacter baumannii in senegal: The paradigm of a common phenomenon in natural reservoirs 10.1371/journal.pone.0039495
Impact of faecal microbiota transplantation on mouse digestive colonization with two extensively resistant bacteria 10.1016/j.jinf.2017.04.008
First report of blaNDM-1-producing Acinetobacter baumannii isolated in Lebanon from civilians wounded during the Syrian war 10.1016/j.ijid.2014.01.004
Mycobacterium ulcerans disease (Buruli ulcer) in Mali: A new potential African endemic country 10.2340/00015555-1942
Establishment of quantitative PCR (qPCR) and culture laboratory facilities in a field hospital in Benin: 1-year results 10.1128/JCM.02131-14
Iterative fecal microbiota transplantations for eradicating digestive colonization with carbapenemase-producing enterobacteriaceae: Is it worth it? 10.1017/ice.2017.173
Extrahuman epidemiology of Acinetobacter baumannii in Lebanon 10.1128/AEM.03824-14
ARG-annot, a new bioinformatic tool to discover antibiotic resistance genes in bacterial genomes 10.1128/AAC.01310-13
Synergistic activity of sulbactam combined with colistin against colistin-resistant Acinetobacter baumannii 10.1016/j.ijantimicag.2011.10.001
Disruption of Candida albicans IFF4 gene involves modifications of the cell electrical surface properties 10.1016/j.colsurfb.2007.03.017
Confirmed case of buruli ulcer, Senegal, 2018 10.3201/eid2503.180707
A case report of Mycoplasma hominis brain abscess identified by MALDI-TOF mass spectrometry 10.1016/j.ijid.2014.08.004
Clinical features of spontaneous partial healing during Mycobacterium ulcerans infection 10.1093/ofid/ofw013
A rare case of Prosthetic Joint Infection associated with Coxiella burnetii 10.1016/j.ijid.2019.07.028
Emergence of resistance to carbapenems in Acinetobacter baumannii in Europe: Clinical impact and therapeutic options 10.1016/j.ijantimicag.2011.10.004
Performance of penicillinase detection tests in Staphylococcus epidermidis: comparison of different phenotypic methods 10.1186/s12866-020-01929-x
Disruption of the GPI protein-encoding gene IFF4 of Candida albicans results in decreased adherence and virulence 10.1007/s11046-009-9201-0
Detection of Acinetobacter baumannii in human head and body lice from Ethiopia and identification of new genotypes 10.1016/j.ijid.2012.05.1024
Colistin-glycopeptide combinations against multidrug-resistant Acinetobacter baumannii in a mouse model of pneumonia 10.2217/fmb-2019-0022
Diversity of Acinetobacter species isolated from different environments in Lebanon: A nationwide study 10.2217/fmb-2016-0082
Buruli Ulcer in South Western Nigeria: A Retrospective Cohort Study of Patients Treated in Benin 10.1371/journal.pntd.0003443
Evaluation of 16S rRNA gene PCR sensitivity and specificity for diagnosis of prosthetic joint infection: A prospective multicenter cross-sectional study 10.1128/JCM.01459-14
The impact of performing bacterial identification and antimicrobial susceptibility testing on bronchoalveolar fluid cultures 24 h a day in a microbiology laboratory 10.1016/j.diagmicrobio.2014.07.009
Emergence of NDM-1 and OXA-72 producing Acinetobacter pittii clinical isolates in Lebanon 10.1016/j.nmni.2016.04.005
Antibacterial activity against 224 clinical bacterial strains of JCA 250 and JCA 251 compounds containing essential oils provided from Aroma Technologies research,Étude de la sensibilité de 224 bactéries isolées d'infections hospitalières vis-à-vis des composés JCA 250 et JCA 251 à base d'huiles essentielles issus de la recherche Aroma Technologies 10.1016/j.patbio.2010.08.001
Stress conditions induced by carvacrol and cinnamaldehyde on Acinetobacter baumannii 10.3389/fmicb.2016.01133
Class 1 integrons in Acinetobacter baumannii: a weak expression of gene cassettes to counterbalance the lack of LexA-driven integrase repression 10.1016/j.ijantimicag.2018.11.012
Semisynthetic Vitamin E Derivatives as Potent Antibacterial Agents against Resistant Gram-Positive Pathogens 10.1002/cmdc.202000792
A case of guilt by association: Water bug bite incriminated in M. ulcerans infection 10.1016/j.ijmyco.2014.01.004
Development of a Dry-Reagent-Based qPCR to Facilitate the Diagnosis of Mycobacterium ulcerans Infection in Endemic Countries 10.1371/journal.pntd.0003606
Staphylococcus saprophyticus: Which beta-lactam? 10.1016/j.ijid.2017.10.001
Rapid detection of carbapenem resistance in Acinetobacter baumannii using matrix-assisted laser desorption ionization-time of flight mass spectrometry 10.1371/journal.pone.0031676
Reply to López-Cortés et al 10.1093/cid/ciaa517
Regional pneumococcus observatories: Evolution of antibiotic resistance and serotype distribution of Streptococcus pneumoniae isolated in France between 2009 and 2013,Observatoires régionaux du pneumocoque : Évolution de la résistance aux antibiotiques et des sérotypes de Streptococcus pneumoniae isolés en France entre 2009 et 2013 10.1016/j.antinf.2015.10.001
High prevalence of contamination of sink drains with carbapenemase-producing Enterobacteriaceae in 4 intensive care units apart from any epidemic context 10.1016/j.ajic.2019.08.007
Histopathological diagnosis of prosthetic joint infection: Does a threshold of 23 neutrophils do better than classification of the periprosthetic membrane in a prospective multicenter study? 10.1128/JCM.00536-18
Wide spread of OXA-23-producing carbapenem-resistant Acinetobacter baumannii belonging to clonal complex II in different hospitals in Lebanon 10.1016/j.ijid.2016.09.017
First report of Oxa-72-producing Acinetobacter calcoaceticus in Lebanon 10.1016/j.nmni.2015.11.010
First report of endocarditis caused by a Pseudoclavibacter species 10.1128/JCM.01388-14
Weight loss and abdominal pain in a 58-year-old-man,Un vent de panique et de questions 10.1016/j.revmed.2014.06.004
Buruli ulcer acquired in Mali: A rare and atypical situation 10.1016/j.tmaid.2014.09.009
Molecular epidemiology of Acinetobacter baumannii in different hospitals in Tripoli, Lebanon using bla OXA-51-like sequence based typing 10.1186/s12866-015-0441-5
Mycoplasma genitalium and Trichomonas vaginalis in France: a point prevalence study in people screened for sexually transmitted diseases 10.1016/j.cmi.2016.10.028
Reservoirs of non-baumannii Acinetobacter species 10.3389/fmicb.2016.00049
Investigation of Acinetobacter baumannii resistance to carbapenems in Marseille hospitals, South of France: A transition from an epidemic to an endemic situation 10.1111/j.1600-0463.2012.02935.x
French Pneumococcus Network (ORP): Epidemiology and antimicrobial resistance of Streptococcus pneumoniae strains isolated in France in 2007,Observatoires régionaux du pneumocoque: Épidémiologie et résistance aux antibiotiques des souches de Streptococcus pneumoniae isolées en France en 2007 10.1016/s1773-035x(08)74865-2
Acinetobacter gandensis sp. nov. isolated from horse and cattle 10.1099/ijs.0.068791-0
Synthesis, crystal structure, characterization of zinc(II), cadmium(II) complexes with 3-thiophene aldehyde thiosemicarbazone (3TTSCH). Biological activities of 3TTSCH and its complexes 10.1016/j.jinorgbio.2009.11.012
Diversity of Acinetobacter baumannii strains isolated in humans, companion animals, and the environment in Reunion Island: An exploratory study 10.1016/j.ijid.2015.05.012
Assessment of the automated multiplex-PCR Unyvero i60 ITI® cartridge system to diagnose prosthetic joint infection: a multicentre study 10.1016/j.cmi.2017.05.017
Molecular analysis of Acinetobacter baumannii strains isolated in Lebanon using four different typing methods 10.1371/journal.pone.0115969
Plasmid-mediated mcr-1 gene in colistin-resistant clinical isolates of Klebsiella pneumoniae in France and Laos 10.1128/AAC.00960-16
Design and stability study of a paediatric oral solution of methotrexate 2 mg/ml 10.1016/j.ijpharm.2015.04.016
Discordance in the minimal inhibitory concentrations of ertapenem for Enterobacter cloacae: Vitek 2 system versus Etest and agar dilution methods 10.1016/j.ijid.2013.09.006
Emergence of the OXA-23 carbapenemase-encoding gene in multidrug-resistant Acinetobacter baumannii clinical isolates from the Principal Hospital of Dakar, Senegal 10.1016/j.ijid.2012.09.007
Decline in antibiotic resistance and changes in the serotype distribution of Streptococcus pneumoniae isolates from children with acute otitis media; a 2001-2011 survey by the French Pneumococcal Network 10.1016/j.cmi.2014.08.009
Comparative in vitro activity of Meropenem, Imipenem and Piperacillin/tazobactam against 1071 clinical isolates using 2 different methods: A French multicentre study 10.1186/1471-2334-10-72
Real-time sequencing to decipher the molecular mechanism of resistance of a clinical pan-drug-resistant Acinetobacter baumannii isolate from Marseille, France 10.1128/AAC.01314-12
Invasive pneumococcal disease incidence in children and adults in France during the pneumococcal conjugate vaccine era: an interrupted time-series analysis of data from a 17-year national prospective surveillance study 10.1016/S1473-3099(20)30165-1
Extended-spectrum β-lactamase Enterobacteriaceae (ESBLE) in intensive care units: strong correlation with the ESBLE colonization pressure in patients but not same species 10.1016/j.jhin.2019.08.007
Fortuitous diagnosis of NDM-1-producing Acinetobacter pittii carriage in a patient from France with no recent history of travel 10.1093/jac/dkw505
Stable and local reservoirs of mycobacterium ulcerans inferred from the nonrandom distribution of bacterial genotypes, Benin 10.3201/eid2603.190573
Lipid nanocapsules: Ready-to-use nanovectors for the aerosol delivery of paclitaxel 10.1016/j.ejpb.2009.06.013
Clonal expansion of the macrolide resistant ST386 within pneumococcal serotype 6C in France 10.1371/journal.pone.0090935
Retrospective detection of the hidden spread of OXA-48-producing Klebsiella pneumoniae in a French teaching hospital 10.1016/j.jinf.2015.05.004
Cell surface properties of two differently virulent strains of acinetobacter baumannii isolated from a patient 10.1139/W11-131
Worldwide emergence of colistin resistance in Klebsiella pneumoniae from healthy humans and patients in Lao PDR, Thailand, Israel, Nigeria and France owing to inactivation of the PhoP/PhoQ regulator mgrB: An epidemiological and molecular study 10.1016/j.ijantimicag.2014.07.020
Epidemiology and prevalence of extended-spectrum β-lactamase- and carbapenemase-producing Enterobacteriaceae in humans, animals and the environment in West and Central Africa 10.1016/j.ijantimicag.2020.106203
In vitro activity of tigecycline on 760 bacterial strains isolated in the hospital university of Angers-2006-2009TEST study,Activité in vitro de la tigécycline vis-à-vis de 760 souches bactériennes isolées au CHU d'Angers-le programme TEST 2006-2009 10.1016/j.patbio.2011.11.008
Assessment of the usefulness of performing bacterial identification and antimicrobial susceptibility testing 24 h a day in a clinical microbiology laboratory 10.1111/j.1469-0691.2009.03044.x
Probabilistic chemotherapy in knee and hip replacement infection: the place of linezolid 10.1007/s10096-019-03594-z
Senegal, a new potential endemic country for Buruli ulcer? 10.1016/j.ijid.2019.09.020
Biotyping of Multidrug-Resistant Klebsiella pneumoniae Clinical Isolates from France and Algeria Using MALDI-TOF MS 10.1371/journal.pone.0061428
High content screening identifies decaprenyl-phosphoribose 2′ epimerase as a target for intracellular antimycobacterial inhibitors 10.1371/journal.ppat.1000645
DNA array analysis of Candida albicans gene expression in response to adherence to polystyrene 10.1016/j.femsle.2005.02.014
Stenotrophomonas maltophilia susceptibility to ceftazidime-avibactam combination versus ceftazidime alone,Sensibilité de Stenotrophomonas maltophilia à l'association ceftazidime-avibactam versus ceftazidime seule 10.1016/j.medmal.2020.01.003
Using Vitek MALDI-TOF mass spectrometry to identify species belonging to the Acinetobacter calcoaceticus-Acinetobacter baumannii complex: A relevant alternative to molecular biology? 10.1016/j.diagmicrobio.2015.06.009
First experience of a multicenter external quality assessment of molecular 16S rRNA gene detection in bone and joint infections 10.1128/JCM.02413-14
Current molecular methods in epidemiological typing of Acinetobacter baumannii 10.2217/FMB.14.63
Distribution and antimicrobial susceptibility of bacteria from adults with community-acquired pneumonia or complicated skin and soft tissue infections in France: The nationwide French PREMIUM study 10.1016/j.diagmicrobio.2015.06.007
First case of OXA-24-producing Acinetobacter baumannii in cattle from Reunion Island, France 10.1016/j.ijantimicag.2016.09.005
High prevalence of closely-related Acinetobacter baumannii in pets according to a multicentre study in veterinary clinics, Reunion Island 10.1016/j.vetmic.2014.01.042
Contribution of molecular biology in the diagnosis of Acinetobacter baumannii infections,Apport de la biologie moléculaire dans le diagnostic des infections à Acinetobacter baumannii 10.1016/S1773-035X(12)71415-6
How many samples and how many culture media to diagnose a prosthetic joint infection: A clinical and microbiological prospective multicenter study 10.1128/JCM.02497-15
Clinical epidemiology of laboratory-confirmed Buruli ulcer in Benin: A cohort study 10.1016/S2214-109X(14)70223-2
Impact of screening and identifying methicillin-resistant Staphylococcus aureus carriers on hand hygiene compliance in 4 intensive care units 10.1016/j.ajic.2010.10.029
Discovery of Q203, a potent clinical candidate for the treatment of tuberculosis 10.1038/nm.3262
First report of carbapenemase-producing Acinetobacter baumannii carriage in pets from the community in France 10.1016/j.ijantimicag.2016.03.012
Evaluation of an immunomagnetic separation method to capture Candida yeasts cells in blood 10.1186/1471-2180-8-157
Carbapenemase-producing Acinetobacter baumannii in two university hospitals in Algeria 10.1099/jmm.0.045807-0
Pays de la Loire pneumococcus observatory: Antimicrobial resistance of Streptococcus pneumoniae in 2007,Observatoire régional du pneumocoque en région Pays de la Loire: résistance de Streptococcus pneumoniae aux antibiotiques en 2007 10.1016/j.patbio.2009.06.009
The virulence variability of different Acinetobacter baumannii strains in experimental pneumonia 10.1016/j.jinf.2009.09.004
Performance of the extended use of the FilmArray® BCID panel kit for bronchoalveolar lavage analysis 10.1007/s11033-019-04710-0
Buruli ulcer disease in Republic of the Congo 10.3201/eid2006.131498
Reservoirs of Acinetobacter baumannii outside the hospital and potential involvement in emerging human community-acquired infections 10.1016/j.ijid.2013.03.021
Measurement of hand hygiene compliance and gloving practices in different settings for the elderly considering the location of hand hygiene opportunities during patient care 10.1016/j.ajic.2010.08.023
Antifungal and antibacterial metabolites from a French poplar type propolis 10.1155/2015/319240
Impact of improving glove usage on the hand hygiene compliance 10.1016/j.ajic.2010.08.022
Impact of a multi-faceted training intervention on the improvement of hand hygiene and gloving practices in four healthcare settings including nursing homes, acute-care geriatric wards and physical rehabilitation units 10.1111/j.1365-2702.2011.03704.x
A case of Ureaplasma parvum meningitis in an adult after transphenoidal ablation of craniopharyngioma 10.1016/j.ijid.2019.04.024
Epidemiology and antimicrobial resistance of Streptococcus pneumoniae in France in 2007: data from the pneumococcus surveillance network. 10.1089/mdr.2010.0031
Mouse model of colonization of the digestive tract with Acinetobacter baumannii and subsequent pneumonia 10.2217/fmb-2016-0203
Acinetobacter pittii isolated more frequently than Acinetobacter baumannii in blood cultures: the experience of a French hospital 10.1016/j.jhin.2018.03.019
Kevin Pethe
Pethe Kevin
ORCID: 0000-0003-0916-8873
Bedaquiline inhibits the ATP synthase in mycobacterium abscessus and is effective in infected zebrafish 10.1128/AAC.01225-17
Biosynthesis and recycling of nicotinamide cofactors in Mycobacterium tuberculosis: An essential role for NAD in nonreplicating bacilli 10.1074/jbc.M800694200
Nanoparticles of Short Cationic Peptidopolysaccharide Self-Assembled by Hydrogen Bonding with Antibacterial Effect against Multidrug-Resistant Bacteria 10.1021/acsami.7b12120
Gluconeogenic carbon flow of tricarboxylic acid cycle intermediates is critical for Mycobacterium tuberculosis to establish and maintain infection 10.1073/pnas.1000715107
Discovery of tetrahydropyrazolopyrimidine carboxamide derivatives as potent and orally active antitubercular agents 10.1021/ml400071a
Inhibitors of energy metabolism interfere with antibiotic-induced death in mycobacteria 10.1074/jbc.RA118.005732
Microbiomes in respiratory health and disease: An Asia-Pacific perspective 10.1111/resp.12971
Next-generation antimicrobials: From chemical biology to first-in-class drugs 10.1007/s12272-015-0645-0
Characterization of Phosphofructokinase Activity in Mycobacterium tuberculosis Reveals That a Functional Glycolytic Carbon Flow Is Necessary to Limit the Accumulation of Toxic Metabolic Intermediates under Hypoxia 10.1371/journal.pone.0056037
Transient requirement of the PrrA-PrrB two-component system for early intracellular multiplication of Mycobacterium tuberculosis 10.1128/IAI.70.5.2256-2263.2002
New 2-Ethylthio-4-methylaminoquinazoline derivatives inhibiting two subunits of cytochrome bc1 in Mycobacterium tuberculosis 10.1371/journal.ppat.1008270
Targeting the Mycobacterium ulcerans cytochrome bc 1 :aa 3 for the treatment of Buruli ulcer 10.1038/s41467-018-07804-8
Target Engagement and Binding Mode of an Antituberculosis Drug to Its Bacterial Target Deciphered in Whole Living Cells by NMR 10.1021/acs.biochem.8b00975
Oxidative phosphorylation as a target space for tuberculosis: Success, caution, and future directions 10.1128/microbiolspec.TBTB2-0014-2016
EthA/R-independent killing of Mycobacterium tuberculosis by ethionamide 10.3389/fmicb.2017.00710
Isolation of Mycobacterium tuberculosis mutants defective in the arrest of phagosome maturation 10.1073/pnas.0401657101
Para-aminosalicylic acid is a prodrug targeting dihydrofolate reductase in mycobacterium tuberculosis 10.1074/jbc.M113.475798
Indolcarboxamide is a preclinical candidate for treating multidrug-resistant tuberculosis 10.1126/scitranslmed.3007355
The heparin-binding haemagglutinin of M. tuberculosis is required for extrapulmonary dissemination 10.1038/35084083
Mycobacterium smegmatis laminin-binding glycoprotein shares epitopes with Mycobacterium tuberculosis heparin-binding haemagglutinin 10.1046/j.1365-2958.2001.02206.x
The protonmotive force is required for maintaining ATP homeostasis and viability of hypoxic, nonreplicating Mycobacterium tuberculosis 10.1073/pnas.0711697105
M. tuberculosis Rv2252 encodes a diacylglycerol kinase involved in the biosynthesis of phosphatidylinositol mannosides (PIMs) 10.1111/j.1365-2958.2006.05174.x
The role of acute and chronic respiratory colonization and infections in the pathogenesis of COPD 10.1111/resp.13032
Triacylglycerol utilization is required for regrowth of in vitro hypoxic nonreplicating Mycobacterium bovis bacillus Calmette-Guerin 10.1128/JB.00530-09
Lead optimization of a novel series of imidazo[1,2-a]pyridine amides leading to a clinical candidate (Q203) as a multi- and extensively-drug- resistant anti-tuberculosis agent 10.1021/jm5003606
A chemical genetic screen in Mycobacterium tuberculosis identifies carbon-source-dependent growth inhibitors devoid of in vivo efficacy 10.1038/ncomms1060
Naturally-Occurring Polymorphisms in QcrB Are Responsible for Resistance to Telacebec in Mycobacterium abscessus 10.1021/acsinfecdis.9b00322
Arylvinylpiperazine amides, a new class of potent inhibitors targeting QcrB of mycobacterium tuberculosis 10.1128/mBio.01276-18
Nitrate respiration protects hypoxic Mycobacterium tuberculosisagainst acid- and reactive nitrogen species stresses 10.1371/journal.pone.0013356
The natural product cyclomarin kills mycobacterium tuberculosis by targeting the ClpC1 subunit of the caseinolytic protease 10.1002/anie.201101740
Active pulmonary targeting against tuberculosis (TB) via triple-encapsulation of Q203, bedaquiline and superparamagnetic iron oxides (SPIOs) in nanoparticle aggregates 10.1080/10717544.2019.1676841
Contribution of high-content imaging technologies to the development of anti-infective drugs 10.1002/cyto.a.22885
Role of the CD137 ligand (CD137L) signaling pathway during Mycobacterium tuberculosis infection 10.1016/j.imbio.2013.08.009
Nutrient-starved, non-replicating Mycobacterium tuberculosis requires respiration, ATP synthase and isocitrate lyase for maintenance of ATP homeostasis and viability 10.1099/mic.0.033084-0
Differential T and B cell responses against Mycobacterium tuberculosis heparin-binding hemagglutinin adhesin in infected healthy individuals and patients with tuberculosis 10.1086/338833
A rheostat mechanism governs the bifurcation of carbon flux in mycobacteria 10.1038/ncomms12527
Mycobacterial heparin-binding hemagglutinin and laminin-binding protein share antigenic methyllysines that confer resistance to proteolysis 10.1073/pnas.162246899
Discovery of Q203, a potent clinical candidate for the treatment of tuberculosis 10.1038/nm.3262
Sensitive profiling of chemically diverse bioactive lipids 10.1194/jlr.M700060-JLR200
Lysosomal killing of Mycobacterium mediated by ubiquitin-derived peptides is enhanced by autophagy 10.1073/pnas.0700036104
Eighty-kilodalton N-terminal moiety of Bordetella pertussis filamentous hemagglutinin: Adherence, immunogenicity, and protective role 10.1128/IAI.70.8.4142-4147.2002
Interaction of human Tamm-Horsfall glycoprotein with Bordetella pertussis toxin 10.1099/00221287-148-4-1193
Enantiomeric glycosylated cationic block co-beta-peptides eradicate Staphylococcus aureus biofilms and antibiotic-tolerant persisters 10.1038/s41467-019-12702-8
Carbon metabolism modulates the efficacy of drugs targeting the cytochrome bc 1 :aa 3 in Mycobacterium tuberculosis 10.1038/s41598-019-44887-9
High-content screening technology combined with a human granuloma model as a new approach to evaluate the activities of drugs against Mycobacterium tuberculosis 10.1128/AAC.03705-14
Methylation-dependent T cell immunity to Mycobacterium tuberculosis heparin-binding hemagglutinin 10.1038/nm1090
Recombinase-based reporter system and antisense technology to study gene expression and essentiality in hypoxic nonreplicating mycobacteria 10.1111/j.1574-6968.2008.01193.x
Isolation and characterization of a hybrid respiratory supercomplex consisting of mycobacterium tuberculosis cytochrome bcc and mycobacterium smegmatis cytochrome aa3 10.1074/jbc.M114.624312
Urease activity represents an alternative pathway for Mycobacterium tuberculosis nitrogen metabolism 10.1128/IAI.06195-11
Targeting bacterial central metabolism for drug development 10.1016/j.chembiol.2014.08.020
Role of ADP-ribosyltransferase activity of pertussis toxin in toxin-adhesin redundancy with filamentous hemagglutinin during Bordetella pertussis infection 10.1128/IAI.69.10.6038-6043.2001
Therapeutic potential of promiscuous targets in Mycobacterium tuberculosis 10.1016/j.coph.2018.06.006
Enhanced bacterial virulence through exploitation of host glycosaminoglycans 10.1046/j.1365-2958.2002.02841.x
Characterization of the heparin-binding site of the mycobacterial heparin-binding hemagglutinin adhesin 10.1074/jbc.275.19.14273
An ethA-ethR-deficient Mycobacterium bovis BCG mutant displays increased adherence to mammalian cells and greater persistence in vivo, which correlate with altered mycolic acid composition 10.1128/IAI.01332-13
Exploiting the synthetic lethality between terminal respiratory oxidases to kill Mycobacterium tuberculosis and clear host infection 10.1073/pnas.1706139114
A high-throughput screen to identify inhibitors of ATP homeostasis in non-replicating mycobacterium tuberculosis 10.1021/cb2004884
Tuberculose, la porte vers la dissémination extra-pulmonaire 10.1051/medsci/200117111220
Mycobacterium tuberculosis with disruption in genes encoding the phosphate binding proteins PstS1 and PstS2 is deficient in phosphate uptake and demonstrates reduced in vivo virulence 10.1128/IAI.73.3.1898-1902.2005
Summary of the Sussex-Huawei locomotion-transportation recognition challenge
Observation of a manifold in the chaotic phase space of an asymmetric optical microcavity
Localized temporal variation of Earth's inner-core boundary from high-quality waveform doublets
Off-axis multi-wavelength dispersion controlling metalens for multi-color imaging
Impact of United States political sanctions on international collaborations and research in Iran